Abstract:Liu et al. identify lysosomal E3 ubiquitin ligase RNF13 as a positive regulator of the TLR‐triggered innate response through high‐content screening. They provide mechanistic insights into the interplay between lysosomal progression, inflammation and ubiquitylation, and highlight the important role of E3 ubiquitin ligases in the regulation of inflammatory responses and related autoimmune diseases. As a highly organized system, endo‐lysosomes play a crucial role in maintaining immune homeostasis. However, the mechanisms involved in regulating endo‐lysosome progression and subsequent inflammatory responses are not fully understood. By screening 103 E3 ubiquitin ligases in regulating endo‐lysosomal acidification, it is discovered that lysosomal RNF13 inhibits lysosome maturation and promotes inflammatory responses mediated by endosomal Toll‐like receptors (TLRs) in macrophages. Mechanistically, RNF13 mediates K48‐linked polyubiquitination of LAMP‐1 at residue K128 for proteasomal degradation. Upon TLRs activation, LAMP‐1 promotes lysosomes maturation, which accelerates lysosomal degradation of TLRs and reduces TLR signaling in macrophages. Furthermore, peripheral blood mononuclear cells (PBMCs) from patients with rheumatoid arthritis (RA) show increased RNF13 levels and decreased LAMP‐1 expression. Accordingly, the immunosuppressive agent hydroxychloroquine (HCQ) can increase the polyubiquitination of RNF13. Taken together, the study establishes a linkage between proteasomal and lysosomal degradation mechanisms for the induction of appropriate innate immune response, and offers a promising approach for the treatment of inflammatory diseases by targeting intracellular TLRs.

LRRC14 Attenuates Toll-like Receptor-Mediated NF-κB Signaling Through Disruption of IKK Complex.

NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK

Identification and characterization of a unique leucine-rich repeat protein (LRRC33) that inhibits Toll-like receptor-mediated NF-κB activation.

IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production

Epigenetically modulated LRRC33 acts as a negative physiological regulator for multiple Toll-like receptors.

LRRC25 Functions as an Inhibitor of NF-κB Signaling Pathway by Promoting p65/RelA for Autophagic Degradation

Lrrc25 Functions As An Inhibitor Of Nf-Kappa B Signaling Pathway By Promoting P65/Rela For Autophagic Degradation

RNF144B inhibits LPS-induced inflammatory responses via binding TBK1

NLRP11 Attenuates Toll-like Receptor Signalling by Targeting TRAF6 for Degradation Via the Ubiquitin Ligase RNF19A.

NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways

IKIP Negatively Regulates NF-κB Activation and Inflammation Through Inhibition of IKKα/β Phosphorylation

NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways

WDR34 is a Novel TAK1-associated Suppressor of the IL-1R/TLR3/TLR4-induced NF-κB Activation Pathway

LRRK2 enhances Nod1/2-mediated inflammatory cytokine production by promoting Rip2 phosphorylation

Reversible Ubiquitination Shapes NLRC5 Function and Modulates NF-κB Activation Switch

The E3 Ubiquitin Protein Ligase LINCR Amplifies the TLR-Mediated Signals through Direct Degradation of MKP1

E3 ligase RNF99 negatively regulates TLR-mediated inflammatory immune response via K48-linked ubiquitination of TAB2

Enhanced TLR-induced NF-κB Signaling and Type I Interferon Responses in NLRC5 Deficient Mice

A Negative Feedback Loop of ICER and NF-κB Regulates TLR Signaling in Innate Immune Responses

TLR5S Negatively Regulates the TLR5M-mediated NF-κB Signaling Pathway in Epinephelus Coioides.

E3 Ubiquitin Ligase RNF13 Suppresses TLR Lysosomal Degradation by Promoting LAMP‐1 Proteasomal Degradation